These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 504036)

  • 1. Hypertension, renal function and gout.
    Gibson T; Highton J; Simmonds HA; Potter CF
    Postgrad Med J; 1979; 55 Suppl 3():21-5. PubMed ID: 504036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Arterial hypertension in gouty nephropathy].
    Gocheva V; Atanasova P
    Vutr Boles; 1986; 25(3):56-9. PubMed ID: 3765579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gout nephropathy and arterial hypertension.
    Gotcheva V; Atanassova P; Todorova L; Astrug A; Dimitrov T
    Przegl Lek; 1985; 42(3):323-4. PubMed ID: 4048510
    [No Abstract]   [Full Text] [Related]  

  • 4. Hereditary nephropathy associated with hyperuricemia and gout.
    Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA
    Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
    Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
    J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mode of renal elimination of uric acid in patients with gout and normal subjects with comparable blood levels. Preliminary results].
    Fontenaille C; Guiheneuc P; Prost A; Heron B; Royer R; Boulange M
    J Urol Nephrol (Paris); 1972 Sep; 78(9):741-3. PubMed ID: 4660654
    [No Abstract]   [Full Text] [Related]  

  • 7. [Various aspects of nephropathy in gout].
    Kawenoki-Minc E; Eyman E; Abgarowicz T; Brzozowska-Jurkowska M; Weryńska-Przybylska J
    Verh Dtsch Ges Rheumatol; 1978; 5():309-11. PubMed ID: 706683
    [No Abstract]   [Full Text] [Related]  

  • 8. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid crystal-induced nephropathy: evidence for a specific renal lesion in a gouty family.
    Farebrother DA; Pincott JR; Simmons HA; Warren DJ; Dillon MJ; Cameron JS
    J Pathol; 1981 Oct; 135(2):159-68. PubMed ID: 7310574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal function in minahasanese patients with chronic gout arthritis and tophi.
    Wibowo C; Kaparang AM; Moeis ES; Kapojos AL
    Acta Med Indones; 2005; 37(2):61-65. PubMed ID: 20066786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies of kidney function, lipid and carbohydrate metabolism in patients with uric arthritis].
    Rohrbach J; Otto W; Reinelt D
    Beitr Rheumatol; 1972; 18():22-6. PubMed ID: 4649113
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH; Brooks CS; Burch RN
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of lead in gout nephropathy.
    Batuman V; Maesaka JK; Haddad B; Tepper E; Landy E; Wedeen RP
    N Engl J Med; 1981 Feb; 304(9):520-3. PubMed ID: 6779160
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
    Siu YP; Leung KT; Tong MK; Kwan TH
    Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does renal impairment protect from gout?
    Youssef P; Brama T; York H; Pickard P; Stewart P; McGill N
    J Rheumatol; 1995 Mar; 22(3):494-6. PubMed ID: 7783068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precocious familial gout with reduced fractional urate clearance and normal purine enzymes.
    Calabrese G; Simmonds HA; Cameron JS; Davies PM
    Q J Med; 1990 May; 75(277):441-50. PubMed ID: 2388995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperuricemia as a risk factor of nephropathy in gout].
    Siniachenko OV; Diadyk AI; Nikolenko IuI; Vasilenko IV
    Ter Arkh; 1988; 60(1):97-101. PubMed ID: 3363519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal impairment and gout.
    Gibson T; Highton J; Potter C; Simmonds HA
    Ann Rheum Dis; 1980 Oct; 39(5):417-23. PubMed ID: 7436572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal damage in hypertension.
    Ruilope LM
    J Cardiovasc Risk; 1995 Feb; 2(1):40-4. PubMed ID: 7606639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia].
    Prost A; Fontenaille C; Guiheneuc P; Héron B; Lucas J
    Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):33-9. PubMed ID: 4820524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.